Madhya Pradesh Cough Syrup Tragedy

Summary of Madhya Pradesh Cough Syrup Deaths

Overview:

• Several deaths of children under five were reported in Parasia, Madhya Pradesh, starting from September 2, as a result of unexplained health complications, eventually attributed to kidney failure linked to a contaminated cough syrup.

Timeline of Events:

• September 2 - 16, 2023: A series of unexplained deaths occurred, leading to urgent investigations by local health authorities:
  • Notable deaths include:
    • Shivam (4) - Sep 2
    • Vidhi (3) - Sep 5
    • Adnan (5) - Sep 7
    • Usaid (4) - Sep 13
    • Rishika (5) - Sep 15
    • Shreya (2) - Sep 16
    • Hitansha (4) - Sep 18
    • Vikas (5) - Sep 18 (led to renal biopsies).

Investigation Findings:

• Renal biopsies revealed damage to nephrons, leading to suspicion of cough syrup contamination.
• Health department faced consent issues for postmortems; toxicology reports were crucial but delayed.
• Door-to-door health survey conducted for children under five, revealing:
  • Population of Parasia block: 284,000
  • Children aged below five: 25,000
  • Symptoms of vomiting, cough, and viral fever identified in 4,658 children.

Health Response:

• On September 23, the Madhya Pradesh government halted the sale of Coldrif Syrup manufactured by Sresan Pharmaceutical after tests linked it to the deaths.
• Reports indicated 48.6% Diethylene Glycol, a toxic industrial chemical found in the syrup, which was deemed to render the contents injurious to health.
• Total syrup distribution: 660 bottles (594 sold in Chhindwara, 66 retrieved during inspections).

Regulatory Actions:

• The Office of the Controller, Food and Drugs Administration, Madhya Pradesh issued a directive to drug inspectors statewide to prevent further distribution of the syrup.
• Similar actions from Rajasthan where cough syrups containing Dextromethorphan were banned following child fatalities.

Public Health Concerns:

• Monitoring efforts faltered as families bypassed local medical facilities, leading to delays in care and further complications.
• Health officials reported that timely community engagement and accurate monitoring could have facilitated earlier interventions.

Conclusion:

• The incident raises significant concerns regarding drug quality standards, regulatory oversight, and the impact of administrative procedures on child health outcomes in Madhya Pradesh and neighboring states. Further investigations are ongoing, alongside efforts to ensure the safety and health of affected children.